Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts

The Original Article was published on 20 January 2017

This article has been updated

Nature Reviews Cancer 17, 254–268 (2017)

In the online html version of this article, Joan Seoane's affiliations were not correct. He is also a member of the EurOPDX Consortium and is at the Vall d'Hebron Institute of Oncology, 08035 Barcelona, the Universitat Autònoma de Barcelona, 08193 Bellaterra, and the Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. This is correct in the print and PDF versions of the article.

Change history

  • 31 October 2017

    When the October issue was published online, this article was initially missed out. It has now been moved into the issue. The article was correctly included in the print edition.

Authors

Additional information

The online version of the original article can be found at 10.1038/nrc.2016.140

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Byrne, A., Alférez, D., Amant, F. et al. Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts. Nat Rev Cancer 17, 632 (2017). https://doi.org/10.1038/nrc.2017.85

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing